JP2018522036A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018522036A5 JP2018522036A5 JP2018505427A JP2018505427A JP2018522036A5 JP 2018522036 A5 JP2018522036 A5 JP 2018522036A5 JP 2018505427 A JP2018505427 A JP 2018505427A JP 2018505427 A JP2018505427 A JP 2018505427A JP 2018522036 A5 JP2018522036 A5 JP 2018522036A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- derived
- biopharmaceutical
- bacterium
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021003185A JP7568519B2 (ja) | 2015-08-04 | 2021-01-13 | 細菌由来ミニ細胞型バイオ医薬品の電離放射線照射滅菌およびその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562200903P | 2015-08-04 | 2015-08-04 | |
| US62/200,903 | 2015-08-04 | ||
| PCT/US2016/045400 WO2017024059A1 (en) | 2015-08-04 | 2016-08-03 | Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021003185A Division JP7568519B2 (ja) | 2015-08-04 | 2021-01-13 | 細菌由来ミニ細胞型バイオ医薬品の電離放射線照射滅菌およびその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018522036A JP2018522036A (ja) | 2018-08-09 |
| JP2018522036A5 true JP2018522036A5 (https=) | 2019-09-19 |
| JP6824960B2 JP6824960B2 (ja) | 2021-02-03 |
Family
ID=57943608
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018505427A Active JP6824960B2 (ja) | 2015-08-04 | 2016-08-03 | 細菌由来ミニ細胞型バイオ医薬品の電離放射線照射滅菌およびその使用方法 |
| JP2021003185A Active JP7568519B2 (ja) | 2015-08-04 | 2021-01-13 | 細菌由来ミニ細胞型バイオ医薬品の電離放射線照射滅菌およびその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021003185A Active JP7568519B2 (ja) | 2015-08-04 | 2021-01-13 | 細菌由来ミニ細胞型バイオ医薬品の電離放射線照射滅菌およびその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10124024B2 (https=) |
| EP (1) | EP3331575A4 (https=) |
| JP (2) | JP6824960B2 (https=) |
| KR (2) | KR102687638B1 (https=) |
| CN (2) | CN113577323B (https=) |
| AU (1) | AU2016301302B2 (https=) |
| WO (1) | WO2017024059A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11167008B2 (en) | 2016-11-23 | 2021-11-09 | Vaxiion Therapeutics, Llc | Immunomodulatory and oncolytic minicells and methods of use |
| AU2018256925B2 (en) | 2017-04-28 | 2024-11-21 | Agrospheres, Inc. | Compositions and methods for the encapsulation and scalable delivery of agrochemicals |
| US11624061B2 (en) | 2017-04-28 | 2023-04-11 | Agrospheres, Inc. | Compositions and methods for enzyme immobilization |
| BR112020005803A2 (pt) | 2017-09-25 | 2020-12-01 | Agrospheres, Inc. | composições e métodos para produção e administração moduláveis de produtos biológicos |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| CN110514772A (zh) * | 2019-08-09 | 2019-11-29 | 中国医学科学院基础医学研究所 | 透明肾细胞癌代谢标志物在肾细胞癌早期筛查和诊断产品中的应用 |
| EP4061802A4 (en) * | 2019-12-23 | 2024-01-24 | Agrospheres, Inc. | Compositions and methods for enhanced uptake of active ingredients for animal health and nutrition |
| MX2022014531A (es) * | 2020-05-21 | 2023-03-03 | Coherus Biosciences Inc | Sistemas y metodos para producir dispositivos de inyeccion esteriles. |
| JP2024504510A (ja) * | 2020-12-11 | 2024-01-31 | アグロスフィアズ，インコーポレイティド | ミニセルの拡張可能な大量生産のためのバイオプロセスシステムおよび方法 |
| WO2022215495A1 (ja) * | 2021-04-08 | 2022-10-13 | 株式会社カネカ | 環状リポペプチド化合物のバイオバーデンの低減方法 |
| CN117618602A (zh) * | 2023-12-18 | 2024-03-01 | 苏州尔生生物医药有限公司 | 一种负载癌细胞裂解物组分的癌症粒子疫苗的终端灭菌方法及其应用 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58131920A (ja) | 1982-01-29 | 1983-08-06 | Nisshin Flour Milling Co Ltd | 鶏の大腸菌症の予防法 |
| US4895724A (en) | 1985-06-07 | 1990-01-23 | Pfizer Inc. | Chitosan compositions for controlled and prolonged release of macromolecules |
| US5314695A (en) * | 1990-11-13 | 1994-05-24 | Corvas International, Inc. | Tissue factor based prothrombin time reagent |
| US5348867A (en) | 1991-11-15 | 1994-09-20 | George Georgiou | Expression of proteins on bacterial surface |
| GB9710699D0 (en) | 1997-05-24 | 1997-07-16 | Danbiosyst Uk | Gastro-retentive controlled release system |
| WO1999059643A2 (en) | 1998-05-20 | 1999-11-25 | Sdg, Inc. | Liposomal delivery complex |
| US20030194798A1 (en) | 2001-05-24 | 2003-10-16 | Surber Mark W. | Minicell compositions and methods |
| US7396822B2 (en) | 2001-05-24 | 2008-07-08 | Vaxiion Therapeutics, Inc. | Immunogenic minicells and methods of use |
| US20030166099A1 (en) | 2001-06-05 | 2003-09-04 | Sabbadini Roger A. | Minicells comprising membrane proteins |
| US20030207833A1 (en) | 2002-02-25 | 2003-11-06 | Neil Berkley | Pharmaceutical compositions with minicells |
| ATE502300T1 (de) | 2002-12-26 | 2011-04-15 | Nitto Boseki Co Ltd | Immunoassay-verfahren |
| CA2516942A1 (en) * | 2003-02-04 | 2004-08-19 | Mcmaster University | Use of quinazoline derivatives or other compounds for inhibiting dihydrofolate reduxtase; screening assay for the identification of novel therapeutics and their cellular targets |
| US7611885B2 (en) | 2003-06-24 | 2009-11-03 | Engeneic Molecular Delivery Pty, Ltd. | Pharmaceutically compatible method for purifying intact bacterial minicells |
| CN101954095B (zh) | 2003-12-09 | 2013-03-13 | 基因分子传递股份有限公司 | 通过源自细菌的完整小细胞将靶基因递送至非吞噬哺乳动物细胞 |
| WO2005058333A1 (de) * | 2003-12-18 | 2005-06-30 | Owen Holding Ltd | Methode zur gewinnung eines biologisch aktiven mit elektroschock behandelten blutserums und seine verwendung |
| US8772013B2 (en) | 2004-02-02 | 2014-07-08 | Engeneic Molecular Delivery Pty Ltd | Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |
| EP1718338B1 (en) | 2004-02-02 | 2015-05-06 | EnGeneIC Molecular Delivery Pty Ltd. | Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |
| WO2006055024A2 (en) | 2004-04-05 | 2006-05-26 | Vaxiion Therapeutics, Inc. | Minicells as vaccines |
| EP2386640B1 (en) | 2004-08-26 | 2015-01-28 | EnGeneIC Molecular Delivery Pty Ltd | Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells |
| US9358292B2 (en) * | 2007-04-08 | 2016-06-07 | Immunolight, Llc | Methods and systems for treating cell proliferation disorders |
| WO2009012493A2 (en) | 2007-07-19 | 2009-01-22 | The Board Of Regents Of The University Of Oklahoma | H-antigen binding polypeptides and methods of use |
| US8236538B2 (en) * | 2007-12-20 | 2012-08-07 | Advanced Technologies And Regenerative Medicine, Llc | Methods for sterilizing materials containing biologically active agents |
| EP3020811A1 (en) | 2008-06-25 | 2016-05-18 | Vaxiion Therapeutics, LLC | Regulated genetic suicide mechanism compositions and methods |
| WO2010057009A1 (en) | 2008-11-14 | 2010-05-20 | Cequent Pharmaceuticals, Inc. | E. coli mediated gene silencing of beta-catenin |
| ES2720659T3 (es) | 2011-02-15 | 2019-07-23 | Vaxiion Therapeutics Llc | Composiciones terapéuticas y métodos para la administración dirigida, mediante minicélulas bacterianas, de moléculas bioactivas basadas en moléculas dirigidas que contienen Fc y anticuerpos |
| CN102349978A (zh) * | 2011-10-27 | 2012-02-15 | 天津中新药业集团股份有限公司达仁堂制药厂 | 生血丸在制备预防低剂量电离辐射致细胞损伤药物中的应用 |
| ES2828092T3 (es) * | 2012-10-02 | 2021-05-25 | Vaxiion Therapeutics Llc | Minicélulas inmunomoduladoras y métodos de uso |
| US11167008B2 (en) * | 2016-11-23 | 2021-11-09 | Vaxiion Therapeutics, Llc | Immunomodulatory and oncolytic minicells and methods of use |
-
2016
- 2016-08-03 KR KR1020237024744A patent/KR102687638B1/ko active Active
- 2016-08-03 KR KR1020187006127A patent/KR102558941B1/ko active Active
- 2016-08-03 CN CN202110761531.2A patent/CN113577323B/zh active Active
- 2016-08-03 JP JP2018505427A patent/JP6824960B2/ja active Active
- 2016-08-03 AU AU2016301302A patent/AU2016301302B2/en active Active
- 2016-08-03 EP EP16833822.6A patent/EP3331575A4/en active Pending
- 2016-08-03 CN CN201680053686.8A patent/CN108348624B/zh active Active
- 2016-08-03 WO PCT/US2016/045400 patent/WO2017024059A1/en not_active Ceased
-
2018
- 2018-02-02 US US15/887,432 patent/US10124024B2/en active Active
- 2018-11-09 US US16/186,290 patent/US11564953B2/en active Active
-
2021
- 2021-01-13 JP JP2021003185A patent/JP7568519B2/ja active Active
-
2023
- 2023-01-30 US US18/161,230 patent/US12427172B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018522036A5 (https=) | ||
| JP2016509003A5 (https=) | ||
| Taj et al. | Effect of dilution, temperature and pH on the lysis activity of T4 phage against E. coli bl21. | |
| EP3197498B1 (en) | Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals&methods for formulation thereof | |
| WO2017024059A8 (en) | Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals and methods of use | |
| Qin et al. | EPSP of L. casei BL23 Protected against the Infection Caused by Aeromonas veronii via Enhancement of Immune Response in Zebrafish | |
| Porfiri et al. | Irradiated non-replicative lactic acid bacteria preserve metabolic activity while exhibiting diverse immune modulation | |
| WO2017113029A1 (es) | Composición bactericida en base a una mezcla de bacteriófagos para el control de peste negra en plantas o partes de las mismas, preferentemente nogal, producida por xanthomonas arborícola pv. juglandis; método de preparación y aplicación | |
| Perera et al. | Leveraging Electron beam (eBeam) Technology for Advancing the development of inactivated vaccines | |
| Shim et al. | Effect of irradiation on kinetic behavior of Salmonella Typhimurium and Staphylococcus aureus in lettuce and damage of bacterial cell envelope | |
| Paliy | Antibacterial effect of" Ecocide C" disinfectant against mycobacteria | |
| Linh et al. | Disinfection of woodblocks of the Nguyen Dynasty of Vietnam by low-energy X-rays | |
| Abdallah et al. | Enhancement of Lactic Acid Bacteria by Gamma Radiation to Inhibit Antibiotic Resistance of some Salmonella spp. | |
| Khoo et al. | Antimicrobial resistance of Salmonella enterica serovar Typhimurium from various meats received in VRI | |
| Ghaffari et al. | Comparison of the disinfectant effects of Nanosil D2 and Korsolex extra solutions on thermoset acrylic resin contaminated with Streptococcus mutans and Bacillus subtilis | |
| Kaoud | Mini-Review: Alternative Therapies of Bovine Mastitis | |
| Focea et al. | Bacteria response to non-thermal physical factors: A study on Staphylococcus aureus | |
| Heydari et al. | Assessment of antimicrobial and viability of Lactobacillus plantarum LZ95 under acidic and bile conditions. | |
| Chopra et al. | Microfabricated Probiotic Formulation for Inhibition of Salmonella | |
| RU2534356C2 (ru) | Способ контроля качества дезинфекции птицеводческих помещений | |
| Mdemu et al. | Antibiotic resistance of Salmonella isolated from commercial chicken feeds in Dar es Salaam, Tanzania. | |
| Tasnim et al. | Isolation and characterization of bacteria from human amniotic membrane and determination of radiation sensitivity of isolates | |
| Nesterenko et al. | Sensitivity of Irradiated Animals to Infection | |
| Ronkainen | Long-term colonization of donor-derived bifidobacteria in recipients of fecal microbiota transplantation | |
| Alsharifi et al. | Virus inactivation using a high dose of gamma-irradiation: a possible approach for safer vaccines against highly infectious agents |